Pombiliti Atga 71904-0200-02

Generic: Cipaglucosidase Alfa-Atga

Package NDC

71904-0200-02

Product NDC: 71904-0200

Manufacturer: Amicus Therapeutics Us, Llc
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 11, 2023
Listing Expires: December 31, 2026
Application: BLA761204

Need to source Pombiliti Atga? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cipaglucosidase Alfa	105 mg/1

Drug Class

Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]alpha-Glucosidases [CS]

Selected Package

71904-0200-02Selected

10 VIAL, GLASS in 1 CARTON (71904-200-02) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Other packages for this product(2)

71904-0200-01

1 VIAL, GLASS in 1 CARTON (71904-200-01) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

View →

71904-0200-03

25 VIAL, GLASS in 1 CARTON (71904-200-03) / 105 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

View →